cells for medical or clinical use; kits comprised of cells and pharmaceuticals for medical or clinical use; pharmaceutical compositions for the treatment of cancer and for immunotherapy; biological compositions for the treatment of cancer and for immunotherapy; cellular immunotherapy compositions, namely, compositions, namely, engineered chimeric antigen receptors (CARs) and t-cell receptors (TCRs)